Defunct Company
Total Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
325
NCT00219843
Intralesional PV-10 Chemoablation of Metastatic Melanoma
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2005
Completion: Aug 31, 2007
NCT00237354
PV-10 Chemoablation of Recurrent Breast Carcinoma
Start: Oct 31, 2005
Completion: Jul 31, 2008
NCT00521053
Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
Phase: Phase 2
Start: Sep 30, 2007
Completion: Jun 30, 2012
NCT00555646
Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis
Start: Nov 30, 2007
Completion: Sep 30, 2008
NCT00690807
A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis
Start: Jun 30, 2008
Completion: Sep 30, 2009
NCT00941278
An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis
Start: Jul 31, 2009
Completion: Apr 30, 2010
NCT01247818
Randomized Study of PH-10 for Psoriasis
Start: Dec 31, 2010
Completion: Mar 31, 2012
NCT01760499
Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study
Role: Collaborator
Start: Jan 24, 2013
Completion: Apr 30, 2017
NCT02322086
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
Start: Jan 31, 2015
Completion: Jun 30, 2017